Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04924907
Other study ID # PI20/00321
Secondary ID GRS 2148/B/2020G
Status Completed
Phase
First received
Last updated
Start date April 21, 2021
Est. completion date December 31, 2023

Study information

Verified date December 2023
Source Instituto de Investigación Biomédica de Salamanca
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is an observational cross-sectional study whose objective is to analyse associations between the intestinal and salivate microbiota with lifestyles (eating patterns, physical activity, tobacco and alcohol consumption), arterial aging and cognitive function. It will take place in five different research units located in Spain


Description:

Aim: To analyze the association of lifestyles (eating patterns, physical activity, tobacco and alcohol consumption) with the intestinal and salivate microbiota and its relationship with arterial aging and cognitive function in subjects without cardiovascular disease in Spain and Portugal. In addition, the mediating role of the intestinal microbiota in the relationship of lifestyles with arterial aging and cognitive function will be analyzed. Design: A cross-sectional study with a case-control analysis, to analyze the association of microbiota patterns with arterial ageing. Setting: the study will develop the research network in health prevention and promotion (Rediapp) and in the Iberian network on arterial structure and the Cancer Research Center of Salamanca. Study population: 1000 subjects aged 45 to 74 years without cardiovascular disease, will be selected. Variables: Demographic, anthropometric and habits (tobacco and alcohol). A dietary pattern through a frequency consumption questionnaire (FFQ), the software of the EVIDENT III and the Mediterranean Diet adherence questionnaire. Physical activity: International Physical Activity Questionnaire (IPAQ), Marshall Questionnaire and Accelerometer, Actigraph. Body composition (Inbody 230 impedance meter). Arterial aging: Medium intimate carotid thickness (Sonosite Micromax); Analysis (PWA) and pulse wave velocity (cf-PWV), (Sphygmocor System). Cardio Ankle Vascular Index (CAVI), ba-PWV and ankle-brachial index (Vasera VS-2000®). With Ambulatory Pulse Wave Analysis (Microsoft®), the PAIx and CAIx and the heart rate variability will be measured. The vascular damage in the retina, heart, kidney, brain and cardiovascular risk will be measured. Intestinal microbiota with the OMNIgene GUT kit (OMR -200) and analysis of the 16S rRNA microbiome profile by massive sequentiation. (Lifestyles, arterial aging, neurocognition, microbiota)


Recruitment information / eligibility

Status Completed
Enrollment 1015
Est. completion date December 31, 2023
Est. primary completion date December 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 74 Years
Eligibility Inclusion Criteria: - People aged 45 to74 years who agree to participate in the study and who not meet any of the exclusion criteria Exclusion Criteria: - Participants with a personal history of cardiovascular disease (ischaemic heart disease or stroke, peripheral arterial disease or Heart Failure) - Participants with a BMI> 40 kg / m2 - Participants diagnosed renal failure in terminal stages (GFR <30 ml / min); - Chronic intestinal inflammatory disease or acute inflammatory process in the past 3 months - Oncology disease diagnosed in the last 5 years or with active treatment - Participants who are in a terminal condition - Consumption of antibiotics last 15 days

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Spain Primary Care Research Unit (APISAL) Salamanca
Spain Primary Care Research Unit-Valladolid Valladolid

Sponsors (3)

Lead Sponsor Collaborator
Instituto de Investigación Biomédica de Salamanca Castilla-León Health Service, Instituto de Salud Carlos III

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pulse Wave Velocity Measurement by SphygmoCor System (meters/seg) 1 year
Secondary Physical Activity Measurement by the International Physical Activity Questionnaire (IPAQ) (min/day) 1 year
Secondary Eating habits Measurement by Food Frequency Questionnaire (FFQ) (kcal/day) 1 year
Secondary Smoking Measurement by a questionnaire of four questions adapted from the WHO MONICA study (Smoking status and cigarettes frequency) 1 year
Secondary Drinking habits Measurement by a frequency alcohol questionnaire (units/day) 1 year
Secondary Body composition Measurement by Inbody 230 device (kg) 1 year
Secondary Carotid intima-media thickness (IMT) Measurement by Sonosite Micromax Ultrasound (mm) 1 year
Secondary Cardio Ankle Vascular Index (CAVI) Measurement by Vasera device 2000 (not units) 1 year
Secondary Cognitive evaluation Measurement by Montreal Cognitive Assessment (MOCA) (points). Range: 0-30 points. A score of 26 points or above is considered normal. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06133634 - Fisetin to Improve Vascular Function in Older Adults Phase 1/Phase 2
Completed NCT05872139 - Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging N/A
Recruiting NCT05095688 - Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEF
Recruiting NCT04558450 - Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN) N/A
Not yet recruiting NCT05943457 - Vitamin K2 Supplementation in Adult Episodic Migraine N/A
Not yet recruiting NCT04900610 - The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis N/A
Completed NCT02226055 - An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka N/A
Completed NCT01559896 - Egg Protein Hydrolysate and Vascular Function N/A
Completed NCT04049162 - Blueberry Enhances Activity and Cognition Through Increased Vascular Efficiency N/A
Not yet recruiting NCT06440369 - Physical Activity and Cardiovascular Risk N/A
Completed NCT05537246 - The Relationship Between Arterial Stiffness and Hemodynamic Responses in Patients With Spinal Anesthesia
Completed NCT06151054 - Relationship Between Aortic Parietal Inflammation on 18F-FDG PET Scan and Arterial Stiffness as a Function of Age
Completed NCT02218268 - Arterial Stiffness in Type I Diabetes Mellitus N/A
Completed NCT00547040 - Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients
Completed NCT02821780 - CADASIL Disease Discovery
Completed NCT05719090 - Acute Effects of Autoregulated and Non-autoregulated Blood Flow Restrictive Exercise on Indices of Arterial Stiffness N/A
Completed NCT04549324 - Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
Completed NCT05022498 - Individual Variability of Coronary Heart Disease Risk Markers and Sleep Responses to Exercise N/A
Completed NCT03415880 - Light Intensity Physical Activity Trial N/A
Completed NCT03560804 - Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs N/A